News
-
Press release. Alfasigma extraneous to the purchase of Ternana Calcio. The purchaser is Pharmaguida
ALFASIGMA NOT INVOLVED IN THE PURCHASE OF TERNANA CALCIO Bologna, 27 June 2023 – With reference to the press rumors circulated today about…
Leggi » -
Ternana Calcio sold to a pharmaceutical company based in Bologna and Pomezia
Terni football. The vice president of Unicusano's board of directors confirms the conclusion of the operation. Closing on July 15th. We are talking about a…
Leggi » -
Fedefarma. Pharmaceutical expenditure data January December 2022
PHARMACEUTICAL EXPENDITURE DATA JANUARY-DECEMBER 2022 The NHS net pharmaceutical expenditure recorded an increase of +1.2% in 2022…
Leggi » -
AstraZeneca is considering spin-off of its China operations
This is why AstraZeneca is considering a spin off of its activities in China The growing geopolitical tensions between China…
Leggi » -
Demonstration in Rome. The numbers of the health disaster
We are facing an unprecedented sustainability crisis of a National Health Service close to the point of non…
Leggi » -
AIOM: AIFA decisions without consulting clinicians. It's chaos at the Italian Medicines Agency
Aiom: "Ready to take a step back with Aifa, but the resignation remains" "At the moment you are only in contact with Palù, In the commissions ...
Leggi » -
On display: Medicine and Advertising. Pain therapy pharmaceutical advertising 1850 – 1970
The Medicine and Advertising exhibition. Pharmaceutical advertising for pain therapy 1850 – 1970, edited by Elisabetta…
Leggi » -
The Regional Regulations on Scientific Information. Updated June 2023
ABRUZZO ASL TERAMO RESOLUTION 227/2019 ACCREDITATION: the relevant request must be sent to the «Drug Scientific Representative Accreditation» Office through…
Leggi » -
For greater transparency, EFPIA has opened the "European Disclosure Gateway" portal
EFPIA, the association of European pharmaceutical companies, for greater transparency regarding payments and benefits provided by the industry to operators…
Leggi » -
SHRO 400 thousand euros for the fight against oncological pathologies
We receive and publish SHRO 400 thousand euros for the fight against oncological diseases and to finance scholarships for researchers…
Leggi »